Medicine Canada

225 readers

1 users here now

A community for Canadian physicians and medical professionals

🍁 While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)

Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub ([email protected])

Rules

No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.
No promotions, advertisements, surveys, or petitions.
Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.
Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.
Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.
No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 2 years ago

MODERATORS

[email protected]

For some prostate cancer patients, new treatment option offers relief – and hope - The Globe and Mail (www.theglobeandmail.com)

submitted 1 day ago by [email protected] to c/[email protected]

0 comments fedilink hide all child comments

The last type of chemotherapy that David Easton tried in his five-year fight against prostate cancer left him living a life that was really no life at all.

The retired Ontario autoworker slept 20 hours a day. His little time awake was spent hunched on or over the toilet at his home in Ayton, a small community about two hours northwest of Toronto.

He and his wife, Ann Easton, decided in February of 2024 that he would stop chemotherapy, even though he had exhausted all other treatments and very much wanted to live.

Then, about a year later, Mr. Easton was presented with a new option: a radioactive drug delivered by IV that would target his cancer and spare his healthy cells, unlike chemotherapy. “The nurse said that chemo was like being hit with a sledgehammer,” Ms. Easton said, “and this stuff is like being tickled with a feather.”

The only catch was that the 73-year-old would have to limit time with his wife and grandchildren for a few days after the drug was injected into his bloodstream because he would be radioactive.

The radiopharmaceutical that Mr. Easton received at London Health Sciences Centre on March 20 is called Pluvicto, and it is part of a new class of treatments that proponents predict will soon be a fourth pillar of cancer care, alongside surgery, chemotherapy and traditional radiation.

no comments (yet)

sorted by: hot top controversial new old

there doesn't seem to be anything here